Wednesday, June 10, 2026
🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6869925

    Inhibition of retrovirus infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6866845

    Compositions and methods for the treatment of sepsis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6863895

    Mycobacterial sulfation pathway proteins and methods of use thereof

    The Regents of the University of California · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6864067

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6858211

    Vaccines against Escherichia coli O157 infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6852324

    Immunization for ebola virus infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6849429

    Viral pseudo-capsids including assembly agonists and antagonists

    The Board of Regents of the University of Texas System · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6849605

    Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

    The Regents of the University of Technology Office of Technology Transfer · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6849610

    Polynucleotide ligands as anti-viral agents

    The Regents of the University of California · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6846652

    Viral vectors having enhanced effectiveness with reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6844010

    Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

    The United States of America as represented by the Secretary of the Army · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6844423

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6841661

    Glycopeptide antibacterial compounds, compositions containing same and methods of using same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6838237

    Antigenically reactive regions of the hepatitis a virus polyprotein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6828416

    Recombinant multivalent malarial vaccine against Plasmodium falciparum

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6824976

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6824769

    Optimal compositions and methods thereof for treating HCV infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6811780

    Methods of using cytokine antagonists to treat HIV infection and AIDS

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6808877

    Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6794174

    Full-length infectious cDNA clones of tick borne flavivirus

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6790449

    Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6790841

    2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6787573

    Antiviral therapy

    Universitair Medisch Centrum Utrecht · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6787145

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6780417

    Transmission blocking immunogen from malaria

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6780969

    Synthetic peptide composition as immunogens for prevention of urinary tract infection

    United Biomedical, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6780414

    METHODS OF IDENTIFYING BACTERIAL GENES THAT ARE INCOMPATIBLE WITH BACTERIAL PATHOGENICITY, AND THE USE OF SUCH GENES, SUCH AS CADA, TO REDUCE PATHOGENICITY IN A BACTERIA OR TO COMBAT PATHOGENIC BACTERIAL INFECTIONS

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6780890

    Compounds and methods for regulating bacterial growth and pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6777179

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6759538

    Substituted diphenyl heterocycles useful for treating HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6750043

    Viral vectors having reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6743577

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6737051

    Cell compositions containing macrophages, presenting anti-infectious and hematopoietic properties

    I.D.M. Immuno-Designed Molecules · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6720415

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6720308

    Anhydrolide derivatives having antibacterial activity

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6713078

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6713056

    Combined preparation for the treatment of neoplasic diseases or of infectious diseases

    I.D.M. Immuno-Designed Molecules · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6713284

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6709649

    RANTES derived peptides with anti-HIV activity

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6706873

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6705556

    Composition and method for inducing tolerance to viral infection in aquatic animals

    First Republic Corporation of America · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6703232

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6696242

    Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6689362

    Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

    Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6689877

    Methods and compositions for the treatment of human immunodeficiency virus infection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6689767

    Triterpenes having antibacterial activity

    Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6686333

    Inhibition of HIV replication using soluble Tat peptide analogs

    The United States of America as represented by the Department of Health and Human Resources · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6686190

    Methods for enhancing the production of viral vaccines in cell culture

    The Regents of the University of California · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.